Stonehage Fleming Financial Services Holdings Ltd purchased a new stake in Danaher Corporation (NYSE:DHR – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 5,317 shares of the conglomerate’s stock, valued at approximately $1,013,000.
Several other hedge funds have also recently modified their holdings of the business. Meeder Asset Management Inc. purchased a new position in Danaher during the second quarter valued at approximately $44,000. MidFirst Bank purchased a new stake in Danaher during the second quarter worth $46,000. Bell Investment Advisors Inc bought a new stake in Danaher during the 2nd quarter valued at $47,000. Fiduciary Financial Advisors bought a new stake in Danaher during the 2nd quarter valued at $53,000. Finally, Solstein Capital LLC purchased a new position in shares of Danaher in the 2nd quarter valued at $58,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Stock Performance
Shares of DHR opened at $215.74 on Friday. The stock has a 50-day moving average of $198.69 and a two-hundred day moving average of $192.35. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The stock has a market cap of $151.67 billion, a P/E ratio of 38.32, a P/E/G ratio of 2.68 and a beta of 0.78.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 price objective on shares of Danaher in a research note on Wednesday, July 22nd. Wells Fargo & Company cut their target price on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Guggenheim reduced their target price on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Evercore reissued an “outperform” rating and set a $230.00 price target on shares of Danaher in a research report on Monday, July 6th. Finally, Stifel Nicolaus lowered their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $228.91.
Read Our Latest Report on Danaher
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
